Prescription painkillers shortage in Canada expected to continue into new year
TORONTO — Pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new…
What we know about the Alzheimer’s drug Health Canada approved
Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer’s disease, raising questions about its effectiveness…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…
Ozempic approved in Canada to reduce kidney decline in people with diabetes – National
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2…